Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$75.49 - $124.16 $472,642 - $777,365
6,261 New
6,261 $776,000
Q4 2022

Jan 31, 2023

BUY
$84.98 - $122.67 $564,522 - $814,896
6,643 New
6,643 $752,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Friedenthal Financial Portfolio

Follow Friedenthal Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friedenthal Financial, based on Form 13F filings with the SEC.

News

Stay updated on Friedenthal Financial with notifications on news.